Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

Scientists have dug up more evidence of the benefits of so-called "magic" mushrooms with the publication of clinical trial results showing how a compound at the root of their nickname leads to ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

For cancer patients with a major depressive disorder, a single dose of psilocybin combined with psychological support can provide sustained relief.

Psilocybin, a psychedelic compound once primarily known as a party drug, is increasingly being recognised for its medical ...

New Zealand has approved the controlled medical use of psilocybin, the psychedelic compound in magic mushrooms, to treat ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

New Zealand has approved the medicinal use of psilocybin, a hallucinogenic compound found in magic mushrooms, to treat ...

Changes to allow over the counter sales of sleep drug melatonin in New Zealand - alongside relaxing rules on magic mushrooms ...